An informed consent was obtained from each individual before enrollment. was about 20% among people with SLE, which was noticeably large but not significantly different from healthy individuals. More severe depression was associated with reduce scores in domains of physical functioning (PF), role limitation due to physical problems (RP) and subsequently physical component overview (PCS) in the SLE group (P < 0. 0001 intended for all). A greater anxiety level was negatively correlated with PF, RP, social functioning (SF), general health (GH) and PCS in the SLE group (P = 0. 01, < 0. 0001, 0. 004, 0. 02 and 0. 005, respectively). Scores of PF and PCS were significantly reduce among patients with SLE compared PP58 to the control group (P = 0. 001 intended for both). Malar rash, photosensitivity, discoid rash, pleuritis, pericarditis, history of seizure and positive Anti-SM Ab were associated with poorer SF (P = 0. 003, 0. 003, 0. 018, 0. 001, < 0. 0001, 0. 021 and 0. 002, respectively). == Findings == The results of this study show that PP58 patients with SLE have poorer HRQoL in physical components whereas the mental component of QoL is relatively similar to healthy individuals. Depressive disorder and stress were not related to clinical manifestations of SLE. However , the SF domain of HRQoL was the most vulnerable component of QoL, which was affected by SLE clinical variables. The high estimated prevalence of depression and anxiety among Rabbit polyclonal to FN1 PP58 patients with SLE requires attention. Keywords: Depression, Stress, Quality of Life, Systemic Lupus Erythematosus == 1 . Background == Multiple organs can be affected by systemic lupus erythematous (SLE). Psychiatric symptoms are also commonly observed among affected individuals (1, 2) which leads to impairment of health-related quality of life (HRQoL) (3). Many investigations possess tried to determine the impact of disease status and psychiatric symptoms on HRQoL among patients with SLE (4, 5). PP58 Moreover, the close correlation between depressive disorder and SLE has been exhibited (6-8). Depressive disorder can also be the initial symptom presented in patients with SLE (9). Due to multifactorial construct of depressive disorder and HRQoL, the mutual relationship between psychiatric symptoms and quality of life (QoL) in people with SLE can be influenced by many variables. The role of disease status as a predictor of QoL as well as impact on the association between depression, stress and HRQoL still needs to be clarified. Previous studies have tried to identify the predictors of depression and anxiety in SLE (10). High prevalence of depressive disorder and stress among Iranian patients with SLE continues to be reported (11); however , the impact of depressive disorder, anxiety and disease-related variables on HRQoL has not yet been explained in Iranian population. Although depression and anxiety are treatable complications accompanied with SLE, inadequate treatment of psychiatric symptoms has been shown (12). Neglected depressive disorder and stress not only can lead to decreased QoL (13, 14), but also severe comorbidities including increased incidence of cardiovascular diseases (15) and suicidal ideation (16) may occur. Therefore , identifications of determinants of depressive disorder and stress and their impact on QoL possess noticeable clinical importance. Depressive disorder and stress are also closely related with each other since they are both associated with bad affectivity (17). Furthermore, the significant correlations between depression, stress and QoL have been exhibited in various populations of patients (18-20). In the present study, we tried to determine the prevalence of depressive disorder and stress among Iranian patients with SLE residing in Kermanshah province and their connection with QoL has been discussed. Moreover, the impact of disease-related variables on severity of depression and anxiety continues to PP58 be assessed. Whether depression, stress and disease-related variables can be determinants of.